In keeping with previous studies which identified high AXL expression and AXL-mediated oncogenic properties in OSCC and head and neck cancers [3, 4, 6], we found AXL to be highly expressed in our cell lines, whereas TYRO3 and MERTK levels were barely detectable (Figure 5A). The gene discussed is AXL; the disease is head and neck cancer.